During the past decade, Florida Hospital Medical Group conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Hospital Medical Group" #1 collaborator was "Helsinn Healthcare SA" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Florida Hospital Medical Group" are "ALK-positive Advanced NSCLC" (1 trials), "Advanced Cholangiocarcinoma" (1 trials), "FGFR2 Gene Mutation" (1 trials) and "Primary Generalized Epilepsy" (1 trials). Many other conditions were trialed in "Florida Hospital Medical Group" in a lesser frequency.

Most popular intervention types in "Florida Hospital Medical Group" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "BGJ398" (1 trials), "Brigatinib" (1 trials), "Cenobamate" (1 trials), "Cisplatin" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Hospital Medical Group" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Florida Hospital Medical Group". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Florida Hospital Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Hospital Medical Group, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".